Delivery Order SPE2DB20D1100-SPE2DB24FA8T8
Award Date 3/22/24
Potential Completion Date 3/25/24
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg. The $5,622.40 award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to support Department of Defense military treatment facilities...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,610,559 capsules of Tamsulosin HCl 0.4 mg. The contract has a completion date of February 12, 2024 and a potential value of $2,459.44. This award is under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a maximum potential value of $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,902.08 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,310,884 capsules of Tamsulosin HCL 0.4 mg. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,001,477 capsules of the generic drug tamsulosin hydrochloride 0.4 mg. The $3,324.39 contract has a performance period through March 19, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract between...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, to provide 4,563,628,875 units of Tamsulosin HCl 0.4 mg capsules. The $3,049.48 order has a completion date of February 13, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division based in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is part of a larger indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,261,614 units of the pharmaceutical drug Tamsulosin HCL 0.4 mg capsules. The $2,310.04 award has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00, through which this delivery order was issued. The contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,691.07 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,565,111,422 units of Tamsulosin HCL 0.4 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical...
- The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order valued at $4,202.05 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The order is for the supply of 1,000 units of tamsulosin hydrochloride 0.4 mg capsules, with a completion date of February 5, 2024. This order is issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- This is a firm-fixed price delivery order contract worth $9,139.98 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 1,000 units of Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,982,190 capsules of Tamsulosin HCL 0.4 mg. The contract has a ceiling value of $2,523.94 and a performance period through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is a child contract under the parent Amerisourcebergen Corporation. The award does not have...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA8T8Delivery Order
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,697.77 to provide 1,000 units of the generic pharmaceutical drug Tamsulosin HCl 0.4 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This award does not have a set-aside designation.
Generated 6/21/24, 9:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 3/22/24 |